Wockhdardt Receives USFDA Nod

USFDA gives approval to Wockhardt for its ANDA (Abbreviated New Drug Application) for 0.1% ophthalmic solution of Olopatadine HCL, manufactured in Montreal, Canada, it is an eye drop and is a generic version of Patanol marketed in the US by Alcon, a subsidiary of Novartis.
Wockhardt Ltd is a biotechnology and pharmaceutical company, which is included manufacturing and marketing of biopharmaceuticalformulations and pharmaceutical, active pharmaceutical ingredient (APIs) and vaccines.
The company’s scrip opened at Rs 614.9 which had a Rs 615.3 and 610.05 of high and low, 63871 NSE+BSE share were traded on the counter and Rs 6689.63cr is a current market cap.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ – 0731-6626222 | Toll Free – 1800-3010-2007 ✔
Give a Missed Call for Free Trial – 09699997717 ✔

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s